Literature DB >> 32810435

Intrinsic Endocardial Defects Contribute to Hypoplastic Left Heart Syndrome.

Yifei Miao1, Lei Tian2, Marcy Martin3, Sharon L Paige4, Francisco X Galdos4, Jibiao Li5, Alyssa Klein3, Hao Zhang2, Ning Ma2, Yuning Wei6, Maria Stewart7, Soah Lee4, Jan-Renier Moonen3, Bing Zhang8, Paul Grossfeld9, Seema Mital10, David Chitayat11, Joseph C Wu2, Marlene Rabinovitch3, Timothy J Nelson12, Shuyi Nie5, Sean M Wu4, Mingxia Gu13.   

Abstract

Hypoplastic left heart syndrome (HLHS) is a complex congenital heart disease characterized by abnormalities in the left ventricle, associated valves, and ascending aorta. Studies have shown intrinsic myocardial defects but do not sufficiently explain developmental defects in the endocardial-derived cardiac valve, septum, and vasculature. Here, we identify a developmentally impaired endocardial population in HLHS through single-cell RNA profiling of hiPSC-derived endocardium and human fetal heart tissue with an underdeveloped left ventricle. Intrinsic endocardial defects contribute to abnormal endothelial-to-mesenchymal transition, NOTCH signaling, and extracellular matrix organization, key factors in valve formation. Endocardial abnormalities cause reduced cardiomyocyte proliferation and maturation by disrupting fibronectin-integrin signaling, consistent with recently described de novo HLHS mutations associated with abnormal endocardial gene and fibronectin regulation. Together, these results reveal a critical role for endocardium in HLHS etiology and provide a rationale for considering endocardial function in regenerative strategies.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ETS1; NOTCH; de novo mutation; endocardium; endothelial to mesenchymal transition; fibronectin; human heart tissue; hypoplastic left heart syndrome; induced pluripotent stem cells; single-cell RNA-seq

Mesh:

Year:  2020        PMID: 32810435      PMCID: PMC7541479          DOI: 10.1016/j.stem.2020.07.015

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  72 in total

Review 1.  Notch signaling in cardiac development and disease.

Authors:  Donal MacGrogan; Meritxell Nus; José Luis de la Pompa
Journal:  Curr Top Dev Biol       Date:  2010       Impact factor: 4.897

Review 2.  Endocardial Notch Signaling in Cardiac Development and Disease.

Authors:  Guillermo Luxán; Gaetano D'Amato; Donal MacGrogan; José Luis de la Pompa
Journal:  Circ Res       Date:  2015-12-03       Impact factor: 17.367

3.  Endocardium Minimally Contributes to Coronary Endothelium in the Embryonic Ventricular Free Walls.

Authors:  Hui Zhang; Wenjuan Pu; Guang Li; Xiuzhen Huang; Lingjuan He; Xueying Tian; Qiaozhen Liu; Libo Zhang; Sean M Wu; Henry M Sucov; Bin Zhou
Journal:  Circ Res       Date:  2016-04-07       Impact factor: 17.367

4.  Fibroblasts in an endocardial fibroelastosis disease model mainly originate from mesenchymal derivatives of epicardium.

Authors:  Hui Zhang; Xiuzhen Huang; Kuo Liu; Juan Tang; Lingjuan He; Wenjuan Pu; Qiaozhen Liu; Yan Li; Xueying Tian; Yue Wang; Libo Zhang; Ying Yu; Hongyan Wang; Ronggui Hu; Fengchao Wang; Ting Chen; Qing-Dong Wang; Zengyong Qiao; Li Zhang; Kathy O Lui; Bin Zhou
Journal:  Cell Res       Date:  2017-08-15       Impact factor: 25.617

Review 5.  Coordinating tissue interactions: Notch signaling in cardiac development and disease.

Authors:  José Luis de la Pompa; Jonathan A Epstein
Journal:  Dev Cell       Date:  2012-02-14       Impact factor: 12.270

6.  VEGF and RANKL regulation of NFATc1 in heart valve development.

Authors:  Michelle D Combs; Katherine E Yutzey
Journal:  Circ Res       Date:  2009-08-06       Impact factor: 17.367

Review 7.  Development of the endocardium.

Authors:  Ian S Harris; Brian L Black
Journal:  Pediatr Cardiol       Date:  2010-02-05       Impact factor: 1.655

Review 8.  The incidence of congenital heart disease.

Authors:  Julien I E Hoffman; Samuel Kaplan
Journal:  J Am Coll Cardiol       Date:  2002-06-19       Impact factor: 24.094

9.  Single-cell analysis of early progenitor cells that build coronary arteries.

Authors:  Tianying Su; Geoff Stanley; Rahul Sinha; Gaetano D'Amato; Soumya Das; Siyeon Rhee; Andrew H Chang; Aruna Poduri; Brian Raftrey; Thanh Theresa Dinh; Walter A Roper; Guang Li; Kelsey E Quinn; Kathleen M Caron; Sean Wu; Lucile Miquerol; Eugene C Butcher; Irving Weissman; Stephen Quake; Kristy Red-Horse
Journal:  Nature       Date:  2018-07-04       Impact factor: 49.962

10.  Endocardial to myocardial notch-wnt-bmp axis regulates early heart valve development.

Authors:  Yidong Wang; Bingruo Wu; Alyssa A Chamberlain; Wendy Lui; Pratistha Koirala; Katalin Susztak; Diana Klein; Verdon Taylor; Bin Zhou
Journal:  PLoS One       Date:  2013-04-01       Impact factor: 3.240

View more
  27 in total

Review 1.  Delving into the Molecular World of Single Ventricle Congenital Heart Disease.

Authors:  Zhiyun Yu; Nicole Min Qian Pek; Mingxia Gu
Journal:  Curr Cardiol Rep       Date:  2022-02-26       Impact factor: 2.931

2.  KMT2D-NOTCH Mediates Coronary Abnormalities in Hypoplastic Left Heart Syndrome.

Authors:  Zhiyun Yu; Xin Zhou; Ziyi Liu; Victor Pastrana-Gomez; Yu Liu; Minzhe Guo; Lei Tian; Timothy J Nelson; Nian Wang; Seema Mital; David Chitayat; Joseph C Wu; Marlene Rabinovitch; Sean M Wu; Michael P Snyder; Yifei Miao; Mingxia Gu
Journal:  Circ Res       Date:  2022-06-28       Impact factor: 23.213

Review 3.  Hypoplastic left heart syndrome (HLHS): molecular pathogenesis and emerging drug targets for cardiac repair and regeneration.

Authors:  Anthony T Bejjani; Neil Wary; Mingxia Gu
Journal:  Expert Opin Ther Targets       Date:  2021-09-15       Impact factor: 6.797

Review 4.  Flow-Mediated Factors in the Pathogenesis of Hypoplastic Left Heart Syndrome.

Authors:  Anum Rahman; Rajiv R Chaturvedi; John G Sled
Journal:  J Cardiovasc Dev Dis       Date:  2022-05-12

Review 5.  Probing single ventricle heart defects with patient-derived induced pluripotent stem cells and emerging technologies.

Authors:  Bailey Hall; Matthew Alonzo; Karen Texter; Vidu Garg; Ming-Tao Zhao
Journal:  Birth Defects Res       Date:  2022-02-24       Impact factor: 2.661

Review 6.  Translational potential of hiPSCs in predictive modeling of heart development and disease.

Authors:  Corrin Mansfield; Ming-Tao Zhao; Madhumita Basu
Journal:  Birth Defects Res       Date:  2022-03-09       Impact factor: 2.661

7.  Coronary blood vessels from distinct origins converge to equivalent states during mouse and human development.

Authors:  Gaetano D'Amato; Kristy Red-Horse; Ragini Phansalkar; Josephine Krieger; Mingming Zhao; Sai Saroja Kolluru; Robert C Jones; Stephen R Quake; Irving Weissman; Daniel Bernstein; Virginia D Winn
Journal:  Elife       Date:  2021-12-15       Impact factor: 8.713

8.  Uncompensated mitochondrial oxidative stress underlies heart failure in an iPSC-derived model of congenital heart disease.

Authors:  Xinxiu Xu; Kang Jin; Abha S Bais; Wenjuan Zhu; Hisato Yagi; Timothy N Feinstein; Phong K Nguyen; Joseph D Criscione; Xiaoqin Liu; Gisela Beutner; Kalyani B Karunakaran; Krithika S Rao; Haoting He; Phillip Adams; Catherine K Kuo; Dennis Kostka; Gloria S Pryhuber; Sruti Shiva; Madhavi K Ganapathiraju; George A Porter; Jiuann-Huey Ivy Lin; Bruce Aronow; Cecilia W Lo
Journal:  Cell Stem Cell       Date:  2022-04-07       Impact factor: 25.269

9.  Modeling Human TBX5 Haploinsufficiency Predicts Regulatory Networks for Congenital Heart Disease.

Authors:  Irfan S Kathiriya; Kavitha S Rao; Giovanni Iacono; W Patrick Devine; Andrew P Blair; Swetansu K Hota; Michael H Lai; Bayardo I Garay; Reuben Thomas; Henry Z Gong; Lauren K Wasson; Piyush Goyal; Tatyana Sukonnik; Kevin M Hu; Gunes A Akgun; Laure D Bernard; Brynn N Akerberg; Fei Gu; Kai Li; Matthew L Speir; Maximilian Haeussler; William T Pu; Joshua M Stuart; Christine E Seidman; J G Seidman; Holger Heyn; Benoit G Bruneau
Journal:  Dev Cell       Date:  2020-12-14       Impact factor: 12.270

Review 10.  Genomic frontiers in congenital heart disease.

Authors:  Sarah U Morton; Daniel Quiat; Jonathan G Seidman; Christine E Seidman
Journal:  Nat Rev Cardiol       Date:  2021-07-16       Impact factor: 49.421

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.